Morningstar3d
Currax Pharmaceuticals: Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA®
March 11, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a specialty pharmaceutical company and manufacturer of the #1 branded oral weight loss medication CONTRAVE® (naltrexone HCl ...
Daily Mail2d
Researchers discover another terrifying side effect caused by Ozempic that some only notice when it's too late
Scientists tracked nearly 3,000 Americans who used either semaglutide, the active drug in Ozempic and Wegovy, or older weight loss drug bupropion-naltrexone, or Contrave. Overall, semaglutide ...
Yahoo Finance17d
Currax Provides Update on Litigation Against Found Health Inc.
Currax cautions prescribers and patients that generic CONTRAVE does not exist. CONTRAVE is a single tablet containing an extended-release fixed-dose combination of 8 mg of naltrexone and 90 mg of ...
The Victoria Advocate18d
Currax Provides Update on Litigation Against Found Health Inc.
Feb. 25, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a specialty pharmaceutical company and manufacturer of the #1 branded oral weight loss medication CONTRAVE ® (naltrexone HCl ...
Currax Pharmaceuticals: Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA®
This peer-reviewed study, based on electronic health record data from more than 24,600 patients followed for over 4.7 years, found no e ...